Home  >  Products  >  BCL11B (B-cell CLL/lymphoma 11B (zinc finger protein)) Blocking Peptide (the C terminal of BCL11B)(100ug)
BCL11B (B-cell CLL/lymphoma 11B (zinc finger protein)) Blocking Peptide (the C terminal of BCL11B)(100ug)

BCL11B (B-cell CLL/lymphoma 11B (zinc finger protein)) Blocking Peptide (the C terminal of BCL11B)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-BCL11B Antibody, made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP39820
Size: 100ug
Weight: 95kDa
Gene: 64919
Format: Lyophilized powder
Target: This gene encodes a C2H2-type zinc finger protein and is closely related to BCL11A, a gene whose translocation may be associated with B-cell malignancies. The specific function of this gene has not yet been determined. Two alternatively spliced transcript variants, which encode distinct isoforms, have been reported.
Alternative names: CTIP-2; CTIP2; RIT1; hRIT1-alpha
See Full Product Listings >